However, allantoin administration significantly lowered TNF-α in the liver tissue compared with the NASH group (31.4±2.2 vs 56.3±3.6, pg/gr wet weight, P<0.01) (Figure 7B). The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.